Opinion/decision on a Paediatric investigation plan (PIP): Adtralza, tralokinumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Skin and subcutaneous tissue disorders, PIP number: P/0012/2024

Submitted by Anonymous (not verified) on 10 December 2025 - 15:18

Opinion/decision on a Paediatric investigation plan (PIP): Adtralza, tralokinumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Skin and subcutaneous tissue disorders, PIP number: P/0012/2024

Opinion/decision on a Paediatric investigation plan (PIP): Rxulti, brexpiprazole, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Psychiatric disorders, PIP number: EMA/PE/0000183866

Submitted by Anonymous (not verified) on 10 December 2025 - 15:17

Opinion/decision on a Paediatric investigation plan (PIP): Rxulti, brexpiprazole, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Psychiatric disorders, PIP number: EMA/PE/0000183866

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness